Specifically, metformin administration (200 mg/kg, i.g) mitigated the development of depression-like behaviours and improved structural plasticity in the hippocampus of social defeat stress (SDS) mice by increasing the expression of p-CREB/ CREB ratio (Fig. 6). Here, CREB1 is linked to depressive symptom measurement.